|
1
|
Dolmans DE, Fukumura D and Jain RK:
Photodynamic therapy for cancer. Nat Rev Cancer. 3:380–387. 2003.
View Article : Google Scholar
|
|
2
|
Moghissi K, Dixon K, Thorpe JA, Stringer M
and Oxtoby C: Photodynamic therapy (PDT) in early central lung
cancer: a treatment option for patients ineligible for surgical
resection. Thorax. 62:391–395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Usuda J, Kato H, Okunaka T, et al:
Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol.
1:489–493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klein A, Babilas P, Karrer S, Landthaler M
and Szeimies RM: Photodynamic therapy in dermatology - an update
2008. J Dtsch Dermatol Ges. 6:839–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Biel MA: Photodynamic therapy treatment of
early oral and laryngeal cancers. Photochem Photobiol.
83:1063–1068. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dougherty TJ, Gomer CJ, Henderson BW, et
al: Photodynamic therapy. J Natl Cancer Inst. 90:889–905. 1998.
View Article : Google Scholar
|
|
7
|
Gollnick SO, Evans SS, Baumann H, et al:
Role of cytokines in photodynamic therapy-induced local and
systemic inflammation. Br J Cancer. 88:1772–1779. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harrison L and Blackwell K: Hypoxia and
anemia: factors in decreased sensitivity to radiation therapy and
chemotherapy? Oncologist. 9(Suppl 5): 31–40. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vaupel P and Harrison L: Tumor hypoxia:
causative factors, compensatory mechanisms, and cellular response.
Oncologist. 9(Suppl 5): 4–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stadtman TC: Selenium biochemistry.
Mammalian selenoenzymes. Ann NY Acad Sci. 899:399–402. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Navarro-Alarcon M and Cabrera-Vique C:
Selenium in food and the human body: a review. Sci Total Environ.
400:115–141. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackson MI and Combs GF Jr: Selenium and
anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr
Metab Care. 11:718–726. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Letavayova L, Vlckova V and Brozmanova J:
Selenium: from cancer prevention to DNA damage. Toxicology.
227:1–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pletcher SD, Macdonald SJ, Marguerie R, et
al: Genome-wide transcript profiles in aging and calorically
restricted Drosophila melanogaster. Curr Biol. 12:712–723. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang JL, Lin YW, Chen HM, et al: Calcium
prevents tumorigenesis in a mouse model of colorectal cancer. PLoS
One. 6:e225662011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson BC and Patterson MS: The physics,
biophysics and technology of photodynamic therapy. Phys Med Biol.
53:R61–R109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zawacka-Pankau J, Krachulec J, Grulkowski
I, Bielawski KP and Selivanova G: The p53-mediated cytotoxicity of
photodynamic therapy of cancer: recent advances. Toxicol Appl
Pharmacol. 232:487–497. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buytaert E, Dewaele M and Agostinis P:
Molecular effectors of multiple cell death pathways initiated by
photodynamic therapy. Biochim Biophys Acta. 1776:86–107.
2007.PubMed/NCBI
|
|
19
|
Milde-Langosch K: The Fos family of
transcription factors and their role in tumourigenesis. Eur J
Cancer. 41:2449–2461. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng QP, Zhou JM, Zhou Q, Pan F, Zhong DP
and Liang HJ: Downregulation of the hexokinase II gene sensitizes
human colon cancer cells to 5-fluorouracil. Chemotherapy.
54:357–363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zijlmans HJ, Fleuren GJ, Baelde HJ, Eilers
PH, Kenter GG and Gorter A: The absence of CCL2 expression in
cervical carcinoma is associated with increased survival and loss
of heterozygosity at 17q11.2. J Pathol. 208:507–517. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hengstermann A, Linares LK, Ciechanover A,
Whitaker NJ and Scheffner M: Complete switch from Mdm2 to human
papillomavirus E6-mediated degradation of p53 in cervical cancer
cells. Proc Natl Acad Sci USA. 98:1218–1223. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferrario A, Von Tiehl K, Wong S, Luna M
and Gomer CJ: Cyclooxygenase-2 inhibitor treatment enhances
photodynamic therapy-mediated tumor response. Cancer Res.
62:3956–3961. 2002.PubMed/NCBI
|
|
24
|
Bequet-Romero M and Lopez-Ocejo O:
Angiogenesis modulators expression in culture cell lines positives
for HPV-16 oncoproteins. Biochem Biophys Res Commun. 277:55–61.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karamysheva AF: Mechanisms of
angiogenesis. Biochemistry (Mosc). 73:751–762. 2008. View Article : Google Scholar
|
|
26
|
Deng CX: BRCA1: cell cycle checkpoint,
genetic instability, DNA damage response and cancer evolution.
Nucleic Acids Res. 34:1416–1426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yen CY, Chen CH, Chang CH, et al: Matrix
metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential
oral cancer markers. Biomarkers. 14:244–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu TC: The role of vascular cell adhesion
molecule-1 in tumor immune evasion. Cancer Res. 67:6003–6006. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zender L, Spector MS, Xue W, et al:
Identification and validation of oncogenes in liver cancer using an
integrative oncogenomic approach. Cell. 125:1253–1267. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma O, Cai WW, Zender L, et al: MMP13,
Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9,
collaborate with p53 deficiency in mouse osteosarcoma progression.
Cancer Res. 69:2559–2567. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khor TO, Gul YA, Ithnin H and Seow HF: A
comparative study of the expression of Wnt-1, WISP-1, survivin and
cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis.
21:291–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie D, Nakachi K, Wang H, Elashoff R and
Koeffler HP: Elevated levels of connective tissue growth factor,
WISP-1, and CYR61 in primary breast cancers associated with more
advanced features. Cancer Res. 61:8917–8923. 2001.PubMed/NCBI
|
